BIG Breast International Group
We will find a cure for breast cancer through global research and collaboration.

BIG 4-04 ICE

The Ibandronate with or without Capecitabine in elderly patients with Early breast cancer (ICE) study is a prospective, multi-center, controlled, openlabel, randomized phase III study.

Coordinating group: GBG

Patients accrual
Start date: June 2004
Closure date: July 2008
Target nr. of patients: 1394
Final accrual: 1409

Reason for closure: reached target accrual Identifier: NCT00196859

To learn more, visit:

Scroll to top

Contact us

Breast International Group (BIG)-aisbl Blvd de Waterloo 121 B-1000 Brussels | Belgium VAT BE 0468 176 240